Efficiency hub
All.Can is gathering examples of best practice in cancer care from around the world to create a learning community around efficient practices and help organisations find and implement potential solutions to common issues.
Submit an example About the efficiency hubThe Global Initiative for Cancer Registry Development
Cancer incidence rates are rising globally, with new cases predicted to increase by almost 50% by 2040. Population-based cancer registries are the gold standard for collection of cancer incidence data, but only 15% of the global population is covered by them. In 2011, the International Agency for Research on Cancer launched the Global Initiative for Cancer Registry Development (GICR) to support low- and middle-income countries and regions to set up their own population-based cancer registries.
Implementing integrated cross-sectional psycho-oncology care in Germany
People with cancer are regularly affected by poor mental health, with 52% reporting psychological distress. However, only 9% of people with cancer in Germany received inpatient psycho-oncological care.
The Alliance of Dedicated Cancer Centers’ Improving Goal Concordant Care Initiative
Goals of care (GoC) are a person’s clinical and personal aims for the management of their condition. People with cancer in the US have reported low rates of GoC conversations with clinicians, and clinicians report a lack of preparedness in conducting these conversations.
Digital toolkit to support employers in handling cancer in the workplace in Denmark
Every year, almost 15,000 working-age people in Denmark are diagnosed with cancer. Three in four people experience challenges returning to work, and one in three say managers are ill-equipped to handle employees being diagnosed with cancer.
Early detection of retinoblastoma in children in French-speaking sub-Saharan Africa
Retinoblastomas have a high mortality rate across French-speaking sub-Saharan African countries, but a 95% cure rate in high-income countries. These poor outcomes are attributed to late diagnosis and treatment, refusal and abandonment of treatment, and poor health infrastructure.
Macmillan Cancer Decision Support Tool: supporting GPs in earlier detection of cancer
The UK has lower survival rates for many types of cancer than the rest of Europe, partly due to delays in diagnosis. When people present with non-specific symptoms, general practitioners may find it difficult to determine whether further clinical investigations are needed. This may delay access to treatment, limit treatment options and reduce survival rates. To address this, Macmillan Cancer Support developed a Cancer Decision Support tool that calculates a person’s risk of having an undiagnosed cancer based on symptoms, medical history and demographic data, and helps GPs consider whether further testing or specialist referral is needed.
National chemotherapy eLibrary – Sweden
A group of researchers and clinicians in Sweden secured funding to develop a nationwide eLibrary of chemotherapy regimens. The library has enabled healthcare professionals to standardise care and reduced the duplication of work across cancer centres.
Achieving efficiency in practice – Lessons learnt from the All.Can Efficiency Hub
In 2022, to mark three years of the Hub, All.Can International examined the lessons that can be learnt from the collection of examples featured on the Efficiency Hub, which are now over 40. Initiatives are selected from across the entire patient care pathway, from diagnosis to palliative care and survivorship; they can be from any country. This think piece, written by The Health Policy Partnership with the input from All.Can members, highlights the kind of solutions that have been identified to address some of the most prominent challenges facing cancer care.
Integrating complementary therapies into cancer care pathways in Tuscany, Italy
The oncology network in Tuscany, Italy has been working since 2013 to integrate complementary therapies into cancer care pathways, enabling people with cancer to manage symptoms and side effects of conventional anticancer treatments in a safe way.